Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Yangrae Cho is listed as Chief Executive Officer at ProxEnrem, based in Cheongju, North Chungcheong, Korea, Republic Of. AeroLeads shows a matched LinkedIn profile for Yangrae Cho.
Yangrae Cho previously worked as Research Director at Syntekabio Inc. and Adjunct Professor at Jeonnam National University. Yangrae Cho holds Postdoctoral Program, Genome Sciences/Genomics from Stanford University.
This section adds company-level context without repeating Yangrae Cho's masked contact details.
Review company-level records connected to Yangrae Cho before choosing the right outreach path.
With a diverse background in both academia and industry, I founded my company in 2017 to pioneer innovative solutions for environmental and human health. In 2020, after studying over 10,000 bacterial strains, I discovered a highly effective Bacillus subtilis strain capable of reducing weight gain and treating fatty liver. Across six rounds of animal model experiments, this strain has shown efficacy comparable to Dapagliflozin, offering remarkable potential as a treatment for fatty liver disease.Currently, I am conducting additional tests to further assess its therapeutic impact, particularly its anti-inflammatory benefits and ability to prevent liver fibrosis. My goal is to develop a breakthrough probiotic treatment for NASH that provides superior results with fewer side effects than conventional medications. Through rigorous research and development, I am committed to delivering innovative health solutions that improve lives학계와 산업계에서 쌓아 올린 경험을 바탕으로, 2017년에 환경과 사람의 건강을 지키는데 도움이 되는 획기적인 제품을 개발하기 위해 회사를 설립했습니다. 2020년에는 10,000종 이상의 박테리아를 조사하여 체중 증가와 지방간 억제에 뛰어난 효능을 가진 Bacillus subtilis 균주를 발견했습니다. 6회의 모델 동물 실험에서 이 균주는 지방간 치료에 특히 탁월한 효과를 보였습니다. 분석 결과, Dapagliflozin과 비교할 만한 효능을 보였습니다. 현재 추가적인 동물 실험을 진행하여 효능을 직접적으로 비교하고 있습니다. 이 균주는 염증 치료 외에도 간 섬유증을 예방하는 효능을 보이며, 현재 치료 효능을 실험적으로 검토하고 있습니다. 저는 NASH 치료를 위해 약물에 비해 부작용이 거의 없는 프로바이오틱 제품을 개발할 계획입니다.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Osongeup, Cheongju, South Korea
Leading innovative R&D in the development of probiotic products leveraging novel Bacillus subtilis strains. Key areas of focus include:1) Preclinical research on NASH treatment using probiotics, aimed at providing effective solutions with fewer side effects than conventional medications.2) Development of animal growth promoter products, recognized with the.
Daejeon, South Korea
Led the development and management of advanced NGS (Next-Generation Sequencing) data mining technologies. Key achievements include:1) Development of NGS-based rare genetic disease detection kits, facilitating cutting-edge diagnostics in genetic research.2) Oversight of custom services, including professional training programs and personnel management to.
Gwangju, Jeonnam, South Korea
Delivered seasonal seminars focused on plant pathology, with occasional coverage of emerging trends in biotechnology development. Engaged students in cutting-edge research discussions, fostering a deeper understanding of these dynamic fields.주로 식물 병리학을 다루고 가끔 생명공학 개발 동향에 대해 다루는 계절별 세미나를 제공했습니다.
Ochang, South Korea
Led the development of targeted gene replacement technology for human cells in vitro, originally adapted from fungal genome editing techniques. While promising progress was made in applying this method to human cells, the project was not completed within the available timeframe, leaving it as an important area for future exploration.사람 세포의 유전자를 대체하는 기술을.
Honolulu, Hawaii, United States
Taught Plant Pathology, specializing in bacterial and fungal diseases, and led a unique course aimed at training students as plant doctors. Conducted research on plant-microbe interactions using Alternaria as a model organism. Developed and applied targeted gene replacement technology for functional genomic research on various pathogenic fungi.
Boston, Massachusetts, United States
Genomic Technology Development: Microarray data mining method, RNA amplification method, and DNA amplification on solid surfaces
Activities and Societies: Taekwondo club: Attended several competitions and earned medals.
Quick answers generated from the profile data available on this page.
Yangrae Cho works for ProxEnrem.
Yangrae Cho is listed as Chief Executive Officer at ProxEnrem.
Yangrae Cho is based in Cheongju, North Chungcheong, Korea, Republic Of while working with ProxEnrem.
Yangrae Cho has worked for Proxenrem, Syntekabio Inc., Jeonnam National University, Korea Research Institute Of Bioscience And Biotechnology (Kribb), and University Of Hawaii At Manoa.
You can use AeroLeads to view verified contact signals for Yangrae Cho at ProxEnrem, including work email, phone, and LinkedIn data when available.
Yangrae Cho holds Postdoctoral Program, Genome Sciences/Genomics from Stanford University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Yangrae Cho you were looking for.
